Analysis of Cardiac Biomarker Racial Discrepancies

Part of paid clinical trials in Dallas, Texas.

Sponsor
Methodist Health System
Study ID
NCT05224557
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • No intervention — OTHER
    No intervention

Study Details

The goal is to review cardiac biomarkers present on admission between African American patients with new onset Heart Failure compared to a comparable cohort of Caucasian patients to establish whether there is a clinically significant difference between the two groups regarding cardiac biomarker levels and initial Heart Failure severity. Hypothesis: Cardiac biomarker levels in African American patients with new onset Heart Failure with Reduced Ejection Fraction will be significantly lower than a Caucasian cohort with new onset Heart Failure with Reduced Ejection Fraction.

Key Dates

Start date
Sep 15, 2021
Status verified
Jan 2026
Primary completion
Aug 15, 2027
Completion
Sep 15, 2028

Study Design

Enrollment
400 participants (estimated)

Arms

  • Arm: New onset HFrEF AA patients
    New onset HFrEF AA patients
  • Arm: New onset HFrEF Caucasian patients
    New onset HFrEF Caucasian patients

Primary Outcome Measure

Baseline NT-proBNP levels on admission [ Time Frame: Chart reviews ill be done for charts generated from April 2017 to August 2020 ]

Locations (1)

FacilityCityStateZIPSite coordinators
Methodist Dallas Medical CenterDallasTexas75203-

Find similar trials in Dallas, TX

By condition
Heart failure
By specialty
CardiologyHeart disease
By research site
Methodist Dallas Medical Center· Dallas, TX

Related Studies